首页 > 最新文献

Journal of Research in Pharmacy Practice最新文献

英文 中文
Drug-related Problems in Hypertensive Patients: A Cross-sectional Study from Indonesia. 高血压患者的药物相关问题:印度尼西亚横断面研究》。
IF 0.8 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2020-10-08 eCollection Date: 2020-07-01 DOI: 10.4103/jrpp.JRPP_20_16
Larasati Arrum Kusumawardani, Retnosari Andrajati, Azizah Nusaibah

Objective: The treatment of hypertension requires special attention because of comorbidities and polypharmacy. In a previous study, polypharmacy has been associated with a high risk of drug-related problems (DRPs). This study aimed to analyze DRPs in Indonesian hypertensive patients focusing on drug therapy effectiveness and adverse drug reactions.

Methods: A cross-sectional study was conducted using medical records' data, prescriptions, and nursing records to observe DRPs that occurred in outpatients with hypertension from February to April 2019. A total of 114 outpatients aged ≥23 years with a primary diagnosis of primary hypertension were included in this study. DRPs were reviewed based on literature, recent guidelines, and drug interaction software. Classification DRPs were done using Indonesian-translated Pharmaceutical Care Network Europe V6.02. The data obtained were analyzed using univariate descriptive analysis.

Findings: Of all participants, 65 (57%) outpatients were found to have DRPs related to treatment effectiveness (54 cases) and adverse drug reactions (36 cases). The primary cause of the problems was an inappropriate drug (94.14%) and dose selection (2.86%). Potential drug interactions were found high (62.14%) in the combination of an antihypertensive agent with other drugs among patients. Overprescribing drugs without clear indications, untreated indications, and subtherapeutic dosage were also reported in this study.

Conclusion: A significant percentage of outpatients being treated for hypertension experienced DRPs. The role of clinical pharmacists and physicians in monitoring drug therapy needs to be prioritized to prevent and resolve DRPs in outpatients with hypertension.

目的:由于合并症和多重用药,高血压的治疗需要特别注意。在之前的一项研究中,多重用药与药物相关问题(DRPs)的高风险有关。本研究旨在分析印尼高血压患者的药物相关问题,重点关注药物治疗效果和药物不良反应:采用病历数据、处方和护理记录进行横断面研究,观察2019年2月至4月期间高血压门诊患者发生的DRP。本研究共纳入了 114 名年龄≥23 岁、主要诊断为原发性高血压的门诊患者。根据文献、最新指南和药物相互作用软件对DRP进行了审查。使用印尼语翻译的Pharmaceutical Care Network Europe V6.02对DRP进行分类。所得数据采用单变量描述性分析法进行分析:在所有参与者中,有 65 名(57%)门诊患者被发现患有与治疗效果(54 例)和药物不良反应(36 例)有关的 DRP。出现问题的主要原因是用药不当(94.14%)和剂量选择不当(2.86%)。发现患者在联合使用一种降压药和其他药物时,潜在的药物相互作用较高(62.14%)。本研究还报告了在没有明确适应症的情况下超量处方药物、未治疗的适应症和治疗剂量不足的情况:结论:在接受高血压治疗的门诊病人中,有相当大比例的人曾经历过药物滥用。临床药剂师和医生在监测药物治疗方面的作用需要优先考虑,以预防和解决门诊高血压患者的药物滥用问题。
{"title":"Drug-related Problems in Hypertensive Patients: A Cross-sectional Study from Indonesia.","authors":"Larasati Arrum Kusumawardani, Retnosari Andrajati, Azizah Nusaibah","doi":"10.4103/jrpp.JRPP_20_16","DOIUrl":"10.4103/jrpp.JRPP_20_16","url":null,"abstract":"<p><strong>Objective: </strong>The treatment of hypertension requires special attention because of comorbidities and polypharmacy. In a previous study, polypharmacy has been associated with a high risk of drug-related problems (DRPs). This study aimed to analyze DRPs in Indonesian hypertensive patients focusing on drug therapy effectiveness and adverse drug reactions.</p><p><strong>Methods: </strong>A cross-sectional study was conducted using medical records' data, prescriptions, and nursing records to observe DRPs that occurred in outpatients with hypertension from February to April 2019. A total of 114 outpatients aged ≥23 years with a primary diagnosis of primary hypertension were included in this study. DRPs were reviewed based on literature, recent guidelines, and drug interaction software. Classification DRPs were done using Indonesian-translated Pharmaceutical Care Network Europe V6.02. The data obtained were analyzed using univariate descriptive analysis.</p><p><strong>Findings: </strong>Of all participants, 65 (57%) outpatients were found to have DRPs related to treatment effectiveness (54 cases) and adverse drug reactions (36 cases). The primary cause of the problems was an inappropriate drug (94.14%) and dose selection (2.86%). Potential drug interactions were found high (62.14%) in the combination of an antihypertensive agent with other drugs among patients. Overprescribing drugs without clear indications, untreated indications, and subtherapeutic dosage were also reported in this study.</p><p><strong>Conclusion: </strong>A significant percentage of outpatients being treated for hypertension experienced DRPs. The role of clinical pharmacists and physicians in monitoring drug therapy needs to be prioritized to prevent and resolve DRPs in outpatients with hypertension.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 3","pages":"140-145"},"PeriodicalIF":0.8,"publicationDate":"2020-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e5/d4/JRPP-9-140.PMC7808178.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38776454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serotonin Toxicity Following Suicide with Citalopram and Lamotrigine: A Rare Case Report and Literature Review. 西酞普兰和拉莫三嗪自杀后血清素毒性:一例罕见病例报告和文献回顾。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2020-10-08 eCollection Date: 2020-07-01 DOI: 10.4103/jrpp.JRPP_19_105
Gholamali Dorooshi, Shafeajafar Zoofaghari, Rokhsareh Meamar

Serotonin toxicity is a common but often unrecognized toxicological condition. In most cases, a combination of two or more serotonergic drugs can cause serotonin syndrome. We describe a case of serotonin toxicity in a 17-year-old woman, secondary to suicidal ingestion of 1000 mg lamotrigine and 400 mg citalopram, which has been rarely reported. Our patient had a medical history of depression and was treated with lamotrigine and citalopram. She was brought to the emergency room with nausea, diaphoresis, agitation, shivering, tremor, vertigo, ataxia, mydriasis, nystagmus, hyperreflexia, myoclonus, tachycardia, tachypnea, and mild fever. The symptoms and signs were resolved within 3 days following hydration, sedation, and cyproheptadine. Minor cardiovascular symptoms are probably due to the less toxic dose of citalopram. Lamotrigine, especially in combination with other serotonergic drugs, should be considered a cause of serotonin toxicity.

血清素毒性是一种常见但通常未被认识到的毒理学状况。在大多数情况下,两种或两种以上的血清素能药物联合使用可引起血清素综合征。我们描述了一例17岁女性血清素毒性,继发于自杀性摄入1000毫克拉莫三嗪和400毫克西酞普兰,这很少有报道。我们的病人有抑郁症病史,并接受拉莫三嗪和西酞普兰的治疗。她因恶心、出汗、躁动、颤抖、震颤、眩晕、共济失调、泪液散失、眼球震颤、反射亢进、肌阵挛、心动过速、呼吸急促和轻度发烧被送到急诊室。在补液、镇静和使用赛庚啶后3天内症状和体征消失。轻微的心血管症状可能是由于西酞普兰的毒性剂量较小。拉莫三嗪,特别是与其他血清素能药物联合使用时,应被认为是血清素毒性的一个原因。
{"title":"Serotonin Toxicity Following Suicide with Citalopram and Lamotrigine: A Rare Case Report and Literature Review.","authors":"Gholamali Dorooshi,&nbsp;Shafeajafar Zoofaghari,&nbsp;Rokhsareh Meamar","doi":"10.4103/jrpp.JRPP_19_105","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_19_105","url":null,"abstract":"<p><p>Serotonin toxicity is a common but often unrecognized toxicological condition. In most cases, a combination of two or more serotonergic drugs can cause serotonin syndrome. We describe a case of serotonin toxicity in a 17-year-old woman, secondary to suicidal ingestion of 1000 mg lamotrigine and 400 mg citalopram, which has been rarely reported. Our patient had a medical history of depression and was treated with lamotrigine and citalopram. She was brought to the emergency room with nausea, diaphoresis, agitation, shivering, tremor, vertigo, ataxia, mydriasis, nystagmus, hyperreflexia, myoclonus, tachycardia, tachypnea, and mild fever. The symptoms and signs were resolved within 3 days following hydration, sedation, and cyproheptadine. Minor cardiovascular symptoms are probably due to the less toxic dose of citalopram. Lamotrigine, especially in combination with other serotonergic drugs, should be considered a cause of serotonin toxicity.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 3","pages":"158-160"},"PeriodicalIF":1.0,"publicationDate":"2020-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bf/78/JRPP-9-158.PMC7808175.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38789577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Increased Risk of Arrhythmia in COVID-19 Patients: Possible Roles of Both the Disease Pathophysiology and Adverse Drug Reactions. COVID-19患者心律失常风险增加:疾病病理生理和药物不良反应的可能作用
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2020-10-08 eCollection Date: 2020-07-01 DOI: 10.4103/jrpp.JRPP_20_63
Ali Rismanbaf
References 1. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. Discovery of a Novel Coronavirus Associated with the Recent Pneumonia Outbreak in Humans and its Potential Bat Origin. BioRxiv; 2020. 2. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061-9. 3. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020;17:259-60. 4. Lazzerini PE, Boutjdir M, Capecchi PL. COVID-19, arrhythmic risk and inflammation: Mind the gap! Circulation 2020. [Ahead of Print]. 5. Rismanbaf A, Zarei S. Liver and kidney injuries in COVID-19 and their effects on drug therapy; a Letter to Editor. Arch Acad Emerg Med 2020;8:e17. Letters to the Editor
{"title":"Increased Risk of Arrhythmia in COVID-19 Patients: Possible Roles of Both the Disease Pathophysiology and Adverse Drug Reactions.","authors":"Ali Rismanbaf","doi":"10.4103/jrpp.JRPP_20_63","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_63","url":null,"abstract":"References 1. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. Discovery of a Novel Coronavirus Associated with the Recent Pneumonia Outbreak in Humans and its Potential Bat Origin. BioRxiv; 2020. 2. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061-9. 3. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020;17:259-60. 4. Lazzerini PE, Boutjdir M, Capecchi PL. COVID-19, arrhythmic risk and inflammation: Mind the gap! Circulation 2020. [Ahead of Print]. 5. Rismanbaf A, Zarei S. Liver and kidney injuries in COVID-19 and their effects on drug therapy; a Letter to Editor. Arch Acad Emerg Med 2020;8:e17. Letters to the Editor","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 3","pages":"165"},"PeriodicalIF":1.0,"publicationDate":"2020-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9a/e5/JRPP-9-165.PMC7808179.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38789580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: Effect of Oral Midazolam in Pain Relief of Patients Need Nasogastric Tube Insertion: A Clinical Trial Study. 口服药咪达唑仑缓解鼻胃管插入患者疼痛的效果:一项临床试验研究。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2020-10-08 eCollection Date: 2020-07-01 DOI: 10.4103/2319-9644.297561

[This corrects the article on p. 112 in vol. 9, PMID: 33102386.].

[这更正了第9卷第112页的文章,PMID: 33102386]。
{"title":"Erratum: Effect of Oral Midazolam in Pain Relief of Patients Need Nasogastric Tube Insertion: A Clinical Trial Study.","authors":"","doi":"10.4103/2319-9644.297561","DOIUrl":"https://doi.org/10.4103/2319-9644.297561","url":null,"abstract":"<p><p>[This corrects the article on p. 112 in vol. 9, PMID: 33102386.].</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 3","pages":"167"},"PeriodicalIF":1.0,"publicationDate":"2020-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fa/f4/JRPP-9-167.PMC7808176.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38855195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pentoxifylline in Prevention of Amphotericin B-induced Nephrotoxicity and Electrolyte Abnormalities. 己酮茶碱预防两性霉素b所致肾毒性和电解质异常。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2020-10-08 eCollection Date: 2020-07-01 DOI: 10.4103/jrpp.JRPP_20_98
Mahsa Panahi-Shokouh, Azadeh Moghaddas, Shirinsadat Badri, Saeedeh Jabalameli, Mahnaz Momenzadeh, Valiollah Mehrzad, Farzaneh Ashrafi

Objective: Amphotericin B is an antifungal agent used to treat serious fungal infections mainly in critically ill patients. Despite its adverse effects including renal toxicity and electrolyte imbalances, amphotericin B remains one of the best choices for antifungal treatment. Information from animal studies has provided a strong scientific basis for the use of pentoxifylline as lowering nephroprotective agent. The present study was designed to evaluate the efficacy of pentoxifylline in preventing renal toxicity and electrolytes imbalances induced by amphotericin B.

Methods: This study was conducted as a randomized controlled trial on 44 patients admitted to Sayyedoshohada Hospital, Isfahan, Iran, from October 2016 to August 2018. Patients were assigned to one of the two groups: Pentoxifylline, 400 mg twice a day, or matching placebo, from the 1st day of amphotericin B therapy till minimum of 7 days. All patients' information including lab data (serum and urine levels of Mg, Na, and K, serum creatinine level, blood urea nitrogen [BUN] and urinary creatinine excretion) were gathered at the time of drug initiation and during the study period. The results were analyzed by SPSS v. 20 software and Repeated measures test was used to assess the differences between groups.

Findings: This study did not show any significant differences between the two groups in terms of all the assessed variables, including serum and urinary levels of electrolytes, and creatinine, as well as the number of cases presented acute kidney injury during the study period.

Conclusion: Despite the positive effects of pentoxifylline in preventing renal complications in previous studies, this study could not show a definitive result in salt wasting or renal damage induced by amphotericin B. So, Designing robust studies with more included samples would be valuable.

目的:两性霉素B是一种主要用于治疗重症真菌感染的抗真菌药物。尽管其副作用包括肾毒性和电解质失衡,两性霉素B仍然是抗真菌治疗的最佳选择之一。来自动物研究的信息为己酮茶碱作为降肾保护剂的使用提供了强有力的科学依据。本研究旨在评价pentoxifylline对两性霉素b所致肾毒性和电解质失衡的预防作用。方法:本研究采用随机对照试验,选取2016年10月至2018年8月在伊朗伊斯法罕Sayyedoshohada医院住院的44例患者。从两性霉素B治疗的第一天开始,患者被分配到两组中的一组:己酮茶碱,400毫克,每天两次,或匹配的安慰剂,直到至少7天。收集所有患者在用药时和研究期间的实验室数据(血清和尿Mg、Na、K水平,血清肌酐水平,血尿素氮[BUN]和尿肌酐排泄量)。采用SPSS v. 20软件对结果进行分析,采用重复测量检验评价组间差异。研究结果:在所有评估变量方面,包括血清和尿液电解质水平、肌酐水平,以及研究期间出现急性肾损伤的病例数,本研究未显示两组之间有任何显著差异。结论:尽管己酮茶碱在既往研究中有预防肾脏并发症的积极作用,但本研究不能明确显示两性霉素b引起的盐消耗或肾脏损害,因此设计更多纳入样本的可靠研究是有价值的。
{"title":"Pentoxifylline in Prevention of Amphotericin B-induced Nephrotoxicity and Electrolyte Abnormalities.","authors":"Mahsa Panahi-Shokouh,&nbsp;Azadeh Moghaddas,&nbsp;Shirinsadat Badri,&nbsp;Saeedeh Jabalameli,&nbsp;Mahnaz Momenzadeh,&nbsp;Valiollah Mehrzad,&nbsp;Farzaneh Ashrafi","doi":"10.4103/jrpp.JRPP_20_98","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_98","url":null,"abstract":"<p><strong>Objective: </strong>Amphotericin B is an antifungal agent used to treat serious fungal infections mainly in critically ill patients. Despite its adverse effects including renal toxicity and electrolyte imbalances, amphotericin B remains one of the best choices for antifungal treatment. Information from animal studies has provided a strong scientific basis for the use of pentoxifylline as lowering nephroprotective agent. The present study was designed to evaluate the efficacy of pentoxifylline in preventing renal toxicity and electrolytes imbalances induced by amphotericin B.</p><p><strong>Methods: </strong>This study was conducted as a randomized controlled trial on 44 patients admitted to Sayyedoshohada Hospital, Isfahan, Iran, from October 2016 to August 2018. Patients were assigned to one of the two groups: Pentoxifylline, 400 mg twice a day, or matching placebo, from the 1<sup>st</sup> day of amphotericin B therapy till minimum of 7 days. All patients' information including lab data (serum and urine levels of Mg, Na, and K, serum creatinine level, blood urea nitrogen [BUN] and urinary creatinine excretion) were gathered at the time of drug initiation and during the study period. The results were analyzed by SPSS v. 20 software and Repeated measures test was used to assess the differences between groups.</p><p><strong>Findings: </strong>This study did not show any significant differences between the two groups in terms of all the assessed variables, including serum and urinary levels of electrolytes, and creatinine, as well as the number of cases presented acute kidney injury during the study period.</p><p><strong>Conclusion: </strong>Despite the positive effects of pentoxifylline in preventing renal complications in previous studies, this study could not show a definitive result in salt wasting or renal damage induced by amphotericin B. So, Designing robust studies with more included samples would be valuable.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 3","pages":"135-139"},"PeriodicalIF":1.0,"publicationDate":"2020-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/76/cc/JRPP-9-135.PMC7808184.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38776452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective Analysis of Drug Prescription Statistics in a Tertiary Care Center in India: Recommendations for Promoting Prudent Utilization of Drugs. 印度三级医疗中心药物处方统计的回顾性分析:促进谨慎用药的建议。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2020-10-08 eCollection Date: 2020-07-01 DOI: 10.4103/jrpp.JRPP_20_29
Ajaya Kumar Sahoo, Dhyuti Gupta, Suryaprakash Dhaneria, Pugazhenthan Thangaraju, Alok Singh

Objective: Drug utilization studies provide information regarding the drug usage pattern in hospital settings, which can be used to promote cost-efficient uses of drugs. The present observational retrospective study was conducted to evaluate the drug utilization pattern in a tertiary care center in India and create a baseline consumption data for the drugs, simultaneously identifying targets for improving drug prescribing pattern.

Methods: The current retrospective cross-sectional study was conducted at All India Institute of Medical Sciences Raipur, wherein the 217 medical records of different departments for August 2019 were chosen randomly (using systematic random sampling) for evaluation. The information was extracted from medical records regarding the basic demographic details, drug strength, route, and total amount, and eventually, the World Health Organization (WHO) core indicators were estimated. Drug utilization data were assessed using the WHO Anatomical Therapeutic Chemical/Defined Daily Dose (ATC-DDD) methodology. Potential drug-drug interactions were also analyzed.

Findings: Most of the records analyzed were of male patients (56.2%). Drugs prescribed by their generic name were 50%. Prescriptions containing injection and antimicrobials were 68.1% and 83.6%, respectively. 49.3% of the patients had received a fixed-dose combination, and 60.9% of drugs belonged to the National List of Essential Medicines 2015. A total of 15 potential drug interactions were found.

Conclusion: Calculated prescribed daily dose of most of the antimicrobials and other groups of drugs was close to the WHO-DDD. Trade name prescription and polypharmacy were very common. Antibiotics accounted for the majority of drug costs.

目的:药物利用研究提供了有关医院环境中药物使用模式的信息,可用于促进药物的成本效益使用。本观察性回顾性研究旨在评估印度某三级医疗中心的药物使用模式,建立药物的基线消费数据,同时确定改进药物处方模式的目标。方法:本研究采用回顾性横断面研究方法,随机抽取印度全印医学科学研究所2019年8月各科室217份病历(采用系统随机抽样)进行评价。从医疗记录中提取有关基本人口统计细节、药物强度、途径和总量的信息,并最终估计出世界卫生组织(世卫组织)的核心指标。使用世卫组织解剖治疗化学/限定日剂量(ATC-DDD)方法评估药物利用数据。还分析了潜在的药物-药物相互作用。结果:以男性患者居多(56.2%)。用通用名开的药占50%。含有注射剂和抗菌剂的处方分别占68.1%和83.6%。49.3%的患者使用固定剂量联合用药,60.9%的患者使用的药物属于2015年国家基本药物目录。总共发现了15种潜在的药物相互作用。结论:大部分抗菌药及其他药物的计算处方日剂量接近WHO-DDD。商品名处方和多药是很常见的。抗生素占药品费用的大部分。
{"title":"Retrospective Analysis of Drug Prescription Statistics in a Tertiary Care Center in India: Recommendations for Promoting Prudent Utilization of Drugs.","authors":"Ajaya Kumar Sahoo,&nbsp;Dhyuti Gupta,&nbsp;Suryaprakash Dhaneria,&nbsp;Pugazhenthan Thangaraju,&nbsp;Alok Singh","doi":"10.4103/jrpp.JRPP_20_29","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_29","url":null,"abstract":"<p><strong>Objective: </strong>Drug utilization studies provide information regarding the drug usage pattern in hospital settings, which can be used to promote cost-efficient uses of drugs. The present observational retrospective study was conducted to evaluate the drug utilization pattern in a tertiary care center in India and create a baseline consumption data for the drugs, simultaneously identifying targets for improving drug prescribing pattern.</p><p><strong>Methods: </strong>The current retrospective cross-sectional study was conducted at All India Institute of Medical Sciences Raipur, wherein the 217 medical records of different departments for August 2019 were chosen randomly (using systematic random sampling) for evaluation. The information was extracted from medical records regarding the basic demographic details, drug strength, route, and total amount, and eventually, the World Health Organization (WHO) core indicators were estimated. Drug utilization data were assessed using the WHO Anatomical Therapeutic Chemical/Defined Daily Dose (ATC-DDD) methodology. Potential drug-drug interactions were also analyzed.</p><p><strong>Findings: </strong>Most of the records analyzed were of male patients (56.2%). Drugs prescribed by their generic name were 50%. Prescriptions containing injection and antimicrobials were 68.1% and 83.6%, respectively. 49.3% of the patients had received a fixed-dose combination, and 60.9% of drugs belonged to the National List of Essential Medicines 2015. A total of 15 potential drug interactions were found.</p><p><strong>Conclusion: </strong>Calculated prescribed daily dose of most of the antimicrobials and other groups of drugs was close to the WHO-DDD. Trade name prescription and polypharmacy were very common. Antibiotics accounted for the majority of drug costs.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 3","pages":"146-150"},"PeriodicalIF":1.0,"publicationDate":"2020-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/32/6b/JRPP-9-146.PMC7808181.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38776453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The Pattern of Intravenous Proton-Pump Inhibitor Utilization at an Academic Medical Center in Riyadh, Saudi Arabia. 在沙特阿拉伯利雅得的一个学术医疗中心静脉注射质子泵抑制剂的使用模式
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2020-10-08 eCollection Date: 2020-07-01 DOI: 10.4103/jrpp.JRPP_20_62
Yahya Ali Mohzari, Ahmed Alsaegh, Syed Mohammed Basheeruddin Asdaq, Sulafah N Al Shanawani, Amani A Albraiki, Amal Bagalb

Objective: This study was designed to evaluate the extent of inappropriate utilization of intravenous proton-pump inhibitors (IV-PPIs) and its financial burden in a Middle Eastern tertiary care university hospital.

Methods: This was an observational, retrospective, cross-sectional study carried out in King Saud University Medical City, Riyadh, Saudi Arabia. During a study period of 6 consecutive weeks, all hospitalized adult patients (age ≥18) who received IV-PPI selected and mapped with their indications. The patient indications analyzed in comparison with the appropriate indications developed based on the evidence from published literature and guidelines.

Findings: A total of 347 patients were identified, with a mean age of 51.5 years, of which 51.9% were male. Of all the patients who received IV-PPIs, 251 (72.3%), 66 (19%), and 30 (8.7%) received for stress ulcer prophylaxis (SUP), peptic ulcer disease (PUD) or gastroesophageal reflux diseases (GERDs), and upper gastrointestinal bleeding, respectively. Overall, only 110 (31.7%) of the 347 patients received IV-PPIs appropriately. The patients with SUP showed the highest percentage of inappropriate use of IV-PPI (80.59%) compared to PUD/GERD (19%). The total cost of inappropriate prescription of IV-PPI was 585,167 Saudi Riyal (SAR) (156,044 USD).

Conclusion: There is a high tendency of IV-PPI's inappropriate prescription in our hospital setting. This large-scale inappropriate prescription of IV-PPI in the hospital setting not only may lead to increased financial burden but also expose patients to number of undesired effects.

目的:本研究旨在评估中东某大学三级医院静脉注射质子泵抑制剂(IV-PPIs)使用不当的程度及其经济负担。方法:这是一项在沙特阿拉伯利雅得的沙特国王大学医学城进行的观察性、回顾性、横断面研究。在连续6周的研究期间,选择所有接受IV-PPI治疗的住院成人患者(年龄≥18岁)并绘制其适应证。分析患者的适应症,并与根据已发表文献和指南的证据制定的适当适应症进行比较。结果:共发现347例患者,平均年龄51.5岁,其中51.9%为男性。在所有接受IV-PPIs的患者中,分别有251人(72.3%)、66人(19%)和30人(8.7%)因应激性溃疡预防(SUP)、消化性溃疡病(PUD)或胃食管反流病(GERDs)和上消化道出血而接受治疗。总体而言,347例患者中只有110例(31.7%)接受了IV-PPIs。与PUD/GERD(19%)相比,SUP患者IV-PPI使用不当的比例最高(80.59%)。IV-PPI处方不当总成本为585,167沙特里亚尔(SAR)(156,044美元)。结论:我院IV-PPI处方不合理的趋势较高。这种大规模不适当的IV-PPI处方在医院设置不仅可能导致增加的经济负担,但也暴露了患者的一些不良影响。
{"title":"The Pattern of Intravenous Proton-Pump Inhibitor Utilization at an Academic Medical Center in Riyadh, Saudi Arabia.","authors":"Yahya Ali Mohzari,&nbsp;Ahmed Alsaegh,&nbsp;Syed Mohammed Basheeruddin Asdaq,&nbsp;Sulafah N Al Shanawani,&nbsp;Amani A Albraiki,&nbsp;Amal Bagalb","doi":"10.4103/jrpp.JRPP_20_62","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_62","url":null,"abstract":"<p><strong>Objective: </strong>This study was designed to evaluate the extent of inappropriate utilization of intravenous proton-pump inhibitors (IV-PPIs) and its financial burden in a Middle Eastern tertiary care university hospital.</p><p><strong>Methods: </strong>This was an observational, retrospective, cross-sectional study carried out in King Saud University Medical City, Riyadh, Saudi Arabia. During a study period of 6 consecutive weeks, all hospitalized adult patients (age ≥18) who received IV-PPI selected and mapped with their indications. The patient indications analyzed in comparison with the appropriate indications developed based on the evidence from published literature and guidelines.</p><p><strong>Findings: </strong>A total of 347 patients were identified, with a mean age of 51.5 years, of which 51.9% were male. Of all the patients who received IV-PPIs, 251 (72.3%), 66 (19%), and 30 (8.7%) received for stress ulcer prophylaxis (SUP), peptic ulcer disease (PUD) or gastroesophageal reflux diseases (GERDs), and upper gastrointestinal bleeding, respectively. Overall, only 110 (31.7%) of the 347 patients received IV-PPIs appropriately. The patients with SUP showed the highest percentage of inappropriate use of IV-PPI (80.59%) compared to PUD/GERD (19%). The total cost of inappropriate prescription of IV-PPI was 585,167 Saudi Riyal (SAR) (156,044 USD).</p><p><strong>Conclusion: </strong>There is a high tendency of IV-PPI's inappropriate prescription in our hospital setting. This large-scale inappropriate prescription of IV-PPI in the hospital setting not only may lead to increased financial burden but also expose patients to number of undesired effects.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 3","pages":"151-154"},"PeriodicalIF":1.0,"publicationDate":"2020-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a8/40/JRPP-9-151.PMC7808177.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38789583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Frequency and Predisposing Factors for Drug-Induced Hypoglycemia in Patients with Type-2 Diabetes Mellitus: A Comment. 2 型糖尿病患者药物诱发低血糖的频率和诱发因素:评论。
IF 0.8 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2020-10-08 eCollection Date: 2020-07-01 DOI: 10.4103/jrpp.JRPP_19_111
Nazanin Gorgzadeh, Maryam Taghizadeh-Ghehi, Aarefeh Jafarzadeh Kohneloo
{"title":"Frequency and Predisposing Factors for Drug-Induced Hypoglycemia in Patients with Type-2 Diabetes Mellitus: A Comment.","authors":"Nazanin Gorgzadeh, Maryam Taghizadeh-Ghehi, Aarefeh Jafarzadeh Kohneloo","doi":"10.4103/jrpp.JRPP_19_111","DOIUrl":"10.4103/jrpp.JRPP_19_111","url":null,"abstract":"","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 3","pages":"166"},"PeriodicalIF":0.8,"publicationDate":"2020-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d7/43/JRPP-9-166.PMC7808180.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38855198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Survey on Medical, Dental, and Pharmacy Students' Knowledge, Attitude, and Practice about Hepatitis B Infection in a Private Medical University of Malaysia. 马来西亚一所私立医科大学医学、牙科和药学学生对乙型肝炎感染的知识、态度和行为的调查
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2020-10-08 eCollection Date: 2020-07-01 DOI: 10.4103/jrpp.JRPP_20_8
Dinesh Kumar Upadhyay, Yuvati Manirajan, Muhammad Zahid Iqbal, Neeraj Paliwal, Sonam Pandey

Objective: The present study aimed to assess the knowledge, attitude, and practice (KAP) of 3rd- and 4th-year medical, dental, and pharmacy students about hepatitis B (HB) infection at a private medical university, Malaysia.

Methods: A cross-sectional, questionnaire-based study was conducted among 482 medical, dental, and pharmacy students of 3rd- and 4th-year degree program of Asian Institute of Medicine, Science and Technology University to assess their KAP about HB infection using 34 prevalidated questions by convenient sampling method. A questionnaire was administered to the students, and their responses were measured at "yes" and "no" scale. Students' responses were entered in SPSS version 22, and quantitative analysis was performed using descriptive statistics and nonparametric tests at P < 0.05.

Findings: The medical, dental, and pharmacy students had good knowledge and practice with positive attitude about HB infection. Mann-Whitney U-test determined a significant difference in knowledge (P < 0.001) and practice (P < 0.001) scores between medical and pharmacy, attitude (P < 0.001) scores between medical and dental, and attitude (P < 0.001) and practice (P < 0.001) scores between pharmacy and dental students. Students' age was correlated with their attitude, practice, and KAP scores and family income with their knowledge, attitude, practice, and KAP scores.

Conclusion: Although students' knowledge and practice were good with positive attitude, all the students did not participate in health education program, screening, and vaccination of hepatitis B virus (HBV) infection which makes them more vulnerable to occupational HBV infection. Hence, it is recommended to organize a regular health education program for the students on screening and vaccination against HBV to prevent its infection.

目的:本研究旨在评估马来西亚一所私立医科大学三年级和四年级医学、牙科和药学学生对乙型肝炎(HB)感染的知识、态度和实践(KAP)。方法:采用横断面、问卷调查的方法,对亚洲科技大学医学院医学、牙科、药学专业三、四年级482名学生进行调查,采用方便抽样的方法,采用34个预验证题,评估他们对HB感染的认知能力。对学生进行问卷调查,并以“是”和“否”来衡量他们的回答。学生的回答输入SPSS version 22,采用描述性统计和P < 0.05的非参数检验进行定量分析。结果:医、牙、药学专业学生对乙肝感染有较好的认识和实践,态度积极。Mann-Whitney u检验确定了医学与药学学生在知识(P < 0.001)和实践(P < 0.001)得分、医学与牙科学生在态度(P < 0.001)得分、药学与牙科学生在态度(P < 0.001)和实践(P < 0.001)得分上的显著差异。学生的年龄与学生的态度、实践和KAP成绩相关,家庭收入与学生的知识、态度、实践和KAP成绩相关。结论:虽然学生的知识和实践情况良好,态度积极,但所有学生都没有参与健康教育计划,筛查和接种乙型肝炎病毒(HBV)感染,使其更容易受到职业性HBV感染。因此,建议定期组织学生进行乙型肝炎病毒筛查和疫苗接种的健康教育,以预防其感染。
{"title":"A Survey on Medical, Dental, and Pharmacy Students' Knowledge, Attitude, and Practice about Hepatitis B Infection in a Private Medical University of Malaysia.","authors":"Dinesh Kumar Upadhyay,&nbsp;Yuvati Manirajan,&nbsp;Muhammad Zahid Iqbal,&nbsp;Neeraj Paliwal,&nbsp;Sonam Pandey","doi":"10.4103/jrpp.JRPP_20_8","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_8","url":null,"abstract":"<p><strong>Objective: </strong>The present study aimed to assess the knowledge, attitude, and practice (KAP) of 3<sup>rd</sup>- and 4<sup>th</sup>-year medical, dental, and pharmacy students about hepatitis B (HB) infection at a private medical university, Malaysia.</p><p><strong>Methods: </strong>A cross-sectional, questionnaire-based study was conducted among 482 medical, dental, and pharmacy students of 3<sup>rd</sup>- and 4<sup>th</sup>-year degree program of Asian Institute of Medicine, Science and Technology University to assess their KAP about HB infection using 34 prevalidated questions by convenient sampling method. A questionnaire was administered to the students, and their responses were measured at \"yes\" and \"no\" scale. Students' responses were entered in SPSS version 22, and quantitative analysis was performed using descriptive statistics and nonparametric tests at <i>P</i> < 0.05.</p><p><strong>Findings: </strong>The medical, dental, and pharmacy students had good knowledge and practice with positive attitude about HB infection. Mann-Whitney U-test determined a significant difference in knowledge (<i>P</i> < 0.001) and practice (<i>P</i> < 0.001) scores between medical and pharmacy, attitude (<i>P</i> < 0.001) scores between medical and dental, and attitude (<i>P</i> < 0.001) and practice (<i>P</i> < 0.001) scores between pharmacy and dental students. Students' age was correlated with their attitude, practice, and KAP scores and family income with their knowledge, attitude, practice, and KAP scores.</p><p><strong>Conclusion: </strong>Although students' knowledge and practice were good with positive attitude, all the students did not participate in health education program, screening, and vaccination of hepatitis B virus (HBV) infection which makes them more vulnerable to occupational HBV infection. Hence, it is recommended to organize a regular health education program for the students on screening and vaccination against HBV to prevent its infection.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 3","pages":"128-134"},"PeriodicalIF":1.0,"publicationDate":"2020-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d9/e3/JRPP-9-128.PMC7808185.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38776451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Artificial Intelligence Decision Support Systems and Liability for Medical Injuries. 人工智能决策支持系统与医疗伤害责任。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2020-10-08 eCollection Date: 2020-07-01 DOI: 10.4103/jrpp.JRPP_20_65
Lise Aagaard
{"title":"Artificial Intelligence Decision Support Systems and Liability for Medical Injuries.","authors":"Lise Aagaard","doi":"10.4103/jrpp.JRPP_20_65","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_65","url":null,"abstract":"","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 3","pages":"125-127"},"PeriodicalIF":1.0,"publicationDate":"2020-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8a/a5/JRPP-9-125.PMC7808182.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38776450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Journal of Research in Pharmacy Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1